NEW YORK, Nov. 7, 2017 /PRNewswire/ --Market barriers affect nearly 15% of multiple sclerosis prescriptions in the EU5 In the EU5 countries, market barriers affect a modest 15% of multiple sclerosis prescriptions, but they're giving market share to most of the brands we surveyed. These...